ORAL-PROTECT I: Oral Asepsis Preventing Transmission During Intubation (ORAL-PROTECT I)
ORAL-PROTECT I: Oral Asepsis for Preoperative Reduction Of Tracheal Bacterial Establishment, Colonization, and Transmission
Postoperative respiratory complications, such as bacterial pneumonia, are common and serious problems after general anesthesia. They can lead to longer hospital stays, more complications, and increased mortality. One possible cause is that bacteria from the mouth and throat enter the lower airways during tracheal intubation.
The mouth and throat naturally contain many bacteria, including potentially harmful microorganisms. During general anesthesia, coughing and swallowing reflexes are reduced or absent. When a tracheal tube is inserted, secretions from the mouth and throat may be carried into the trachea. The tube may also support the movement of contaminated fluid into the lower airways.
ORAL-PROTECT I is a prospective, randomized, controlled study. It investigates whether simple oral hygiene before surgery can reduce the transfer of bacteria into the trachea during airway management under general anesthesia.
The study includes patients aged 60 years or older undergoing elective surgery under general anesthesia with tracheal intubation. Participants are randomly assigned to an intervention group or a control group. The intervention group performs oral hygiene immediately before anesthesia. This includes brushing the teeth and tongue for about 3 minutes, followed by rinsing and gargling for about 1 minute with a chlorhexidine antiseptic solution. The control group receives standard care without additional oral hygiene.
Oral, pharyngeal, and tracheal swabs will be collected at predefined time points. The primary outcome is based on the perioperative tracheal bacterial load, sampled every 30 minutes and assessed at two hours after induction of anesthesia. The co-primary outcome is based on the oral bacterial load immediately before endotracheal intubation.
Secondary outcomes include changes in oral and tracheal bacterial load over time and identification of the microorganisms detected. The study aims to clarify early bacterial transfer during airway management and to evaluate whether a simple preoperative oral hygiene measure can reduce this process.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
ORAL-PROTECT I is a prospective, randomized, controlled, unblinded, parallel-group trial investigating whether preoperative oral hygiene can reduce early bacterial transmission from the mouth and throat into the trachea during airway management under general anesthesia.
Postoperative respiratory complications, including bacterial pneumonia, are common and clinically relevant adverse events after general anesthesia. They can contribute to increased morbidity, prolonged hospital stay, and mortality. One possible mechanism is the transmission of bacteria from the oral cavity and pharynx into the lower airways during tracheal intubation. The oral cavity and pharynx naturally contain a broad bacterial flora, including potentially pathogenic microorganisms. During general anesthesia, protective swallowing and coughing reflexes are reduced or absent. During tracheal intubation, bacteria-contaminated secretions from the mouth and throat may enter the trachea and lower airways.
The study includes patients aged 60 years or older undergoing elective surgery under general anesthesia with tracheal intubation. Potentially eligible patients are screened before surgery. Patients are screened for eligibility during pre-admission testing and are approached for study participation. On the day of surgery, patients are reassessed for eligibility before randomization to confirm that eligibility criteria are still met. Patients who performed oral hygiene less than four hours before induction are excluded before randomization.
Eligible participants are randomly assigned to either the intervention group or the control group using a REDCap-based randomization tool. Participants in the intervention group undergo supervised oral hygiene immediately before induction of anesthesia, consisting of 3 minutes of tongue and tooth brushing and 1 minute of chlorhexidine gargling. Participants in the control group receive standard clinical care without additional preoperative oral hygiene measures. All other perioperative procedures, including anesthetic management, airway management, surgical care, and postoperative treatment, are at the discretion of the treating anesthesiologist and independent of study participation.
Bacterial load is assessed using swab-based microbiological sampling at predefined time points. Samples are collected from the oral cavity, pharynx, and trachea to describe perioperative bacterial contamination and its development over time. The perioperative tracheal bacterial load is sampled at 30-minute intervals.
Sample handling and microbiological processing follow a standardized operating procedure. This includes uniform transport conditions, timely laboratory processing, neutralization of residual antiseptic activity, serial dilution, plating on appropriate culture media, aerobic incubation, and quantitative colony counting. Samples from both study groups are processed identically to minimize systematic bias and allow reliable comparison of bacterial load. Additional assessments include the intraoperative course of tracheal bacterial load, tracheal bacterial load before extubation, oral bacterial load approximately 24 hours after surgery, and qualitative microbiological characterization of detected bacteria. Adverse events are evaluated after the intervention and anesthesia.
The study aims to provide insight into early perioperative bacterial transmission during airway management and to evaluate whether a simple, low-risk preoperative oral hygiene intervention can influence bacterial contamination of the trachea under general anesthesia.
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: Béla-Simon Paschold, M.D.
- Telefonnummer: +49-731-50060390
- E-Mail: bela-simon.paschold@uniklinik-ulm.de
Studieren Sie die Kontaktsicherung
- Name: Physician on Duty
- Telefonnummer: +49-731-50060043
Studienorte
-
-
Baden-Wurttemberg
-
Ulm, Baden-Wurttemberg, Deutschland, 89081
- Ulm University Medical Center, Department of Anesthesiology and Intensive Care Medicine
-
Kontakt:
- Béla-Simon Paschold, M.D.
- Telefonnummer: +49-731-50060390
- E-Mail: bela-simon.paschold@uniklinik-ulm.de
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Age ≥ 60 years
- Elective surgery under general anesthesia with endotracheal intubation
- Expected duration of surgery ≥ 2 hours
- Ability to provide written informed consent
Exclusion Criteria:
- Systemic antibiotic therapy within 7 days before surgery
- Planned postoperative systemic antibiotic therapy
- Known hypersensitivity or allergy to chlorhexidine
- Pneumonia or clinically relevant respiratory infection within 7 days before surgery
- Inability to perform the study intervention as intended
- Preoperative oral hygiene on the day of surgery, less than four hours prior to induction of the general anesthesia
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Kein Eingriff: Standard of care
Standard clinical care without additional preoperative oral hygiene or oral decontamination measures before induction of general anesthesia.
|
|
|
Aktiver Komparator: Preoperative oral decontamination with chlorhexidine & tooth & tongue brushing
Supervised preoperative oral decontamination immediately before induction of general anesthesia using chlorhexidine for 1 minute & tooth/tongue brushing for 3 minutes
|
The intervention consists of supervised preoperative oral decontamination performed in the operating room holding/ induction area immediately before induction of general anesthesia.
Participants brush their teeth and tongue for 3 minutes, followed by a rinse with chlorhexidine oral antiseptic solution for 1 minute.
The intervention is performed right before endotracheal intubation.
All other perioperative procedures are at the discretion of the anesthesiologist in the room.
|
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in tracheal bacterial load at 2 hours after anesthesia induction
Zeitfenster: At 2 hours after induction and intubation
|
The primary outcome is the change in tracheal bacterial load, defined through tracheal swab obtained 2 hours after induction of anesthesia.
|
At 2 hours after induction and intubation
|
|
Change in oral bacterial load
Zeitfenster: Immediately before endotracheal intubation.
|
The co-primary outcome is the peri-interventional change in oral bacterial load due to the oral hygiene measures obtained through oral swabs immediately before endotracheal intubation.
|
Immediately before endotracheal intubation.
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Intraoperative development of tracheal bacterial load
Zeitfenster: Every 30 minutes intraoperatively from endotracheal intubation until washout of anesthesia prior to extubation.
|
This secondary outcome assesses the intraoperative development of tracheal bacterial load during the surgery.
Serial tracheal samples are collected every 30 minutes until extubation.
|
Every 30 minutes intraoperatively from endotracheal intubation until washout of anesthesia prior to extubation.
|
|
Change of tracheal bacterial load immediately before extubation
Zeitfenster: Immediately before extubation.
|
This secondary outcome assesses the tracheal bacterial load immediately before extubation.
|
Immediately before extubation.
|
|
Change of oral bacterial load 24 hours postoperatively
Zeitfenster: Approximately 24 hours postoperatively, with a tolerance of ±2 hours.
|
This secondary outcome assesses the change in oral bacterial load obtained 24 (± 2) hours after surgery.
|
Approximately 24 hours postoperatively, with a tolerance of ±2 hours.
|
|
Qualitative microbiological characterization of bacteria detected in tracheal samples
Zeitfenster: Tracheal swabs are obtained from right after intubation until extubation. For the primary outcome all samples are plated. If Colony Forming Units (CFU) occur on those within 48 hours, characterization will be performed.
|
Descriptive analysis of colony forming bacteria that were obtained through tracheal swabs.
|
Tracheal swabs are obtained from right after intubation until extubation. For the primary outcome all samples are plated. If Colony Forming Units (CFU) occur on those within 48 hours, characterization will be performed.
|
|
Safety events related to the oral hygiene intervention
Zeitfenster: From the start of the oral hygiene intervention until approximately 24 hours postoperatively.
|
This secondary outcome assesses safety events potentially related to the preoperative oral hygiene intervention, including oral mucosal irritation, discomfort, intolerance of the mouth rinse, or other adverse events.
|
From the start of the oral hygiene intervention until approximately 24 hours postoperatively.
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Pneumatikos IA, Dragoumanis CK, Bouros DE. Ventilator-associated pneumonia or endotracheal tube-associated pneumonia? An approach to the pathogenesis and preventive strategies emphasizing the importance of endotracheal tube. Anesthesiology. 2009 Mar;110(3):673-80. doi: 10.1097/ALN.0b013e31819868e0.
- Naumova EA, Weber L, Pankratz V, Czenskowski V, Arnold WH. Bacterial viability in oral biofilm after tooth brushing with amine fluoride or sodium fluoride. Arch Oral Biol. 2019 Jan;97:91-96. doi: 10.1016/j.archoralbio.2018.10.013. Epub 2018 Oct 17.
- Shuai Y, Wang X, Chen S, Huang T, Wang Z, Zhang Y. Preoperative oral hygiene treatment reduces bacterial transport and colonization during intubation for orthopedic surgery. J Oral Sci. 2024;66(2):134-138. doi: 10.2334/josnusd.23-0425.
- Okochi M, Nomura S, Kaga C, Honda H. Peptide array-based screening of human mesenchymal stem cell-adhesive peptides derived from fibronectin type III domain. Biochem Biophys Res Commun. 2008 Jun 20;371(1):85-9. doi: 10.1016/j.bbrc.2008.04.019. Epub 2008 Apr 14.
- Fourrier F, Duvivier B, Boutigny H, Roussel-Delvallez M, Chopin C. Colonization of dental plaque: a source of nosocomial infections in intensive care unit patients. Crit Care Med. 1998 Feb;26(2):301-8. doi: 10.1097/00003246-199802000-00032.
- Scannapieco FA, Stewart EM, Mylotte JM. Colonization of dental plaque by respiratory pathogens in medical intensive care patients. Crit Care Med. 1992 Jun;20(6):740-5. doi: 10.1097/00003246-199206000-00007.
- Cozowicz C, Zhong H, Reisinger L, Illescas A, Giannakis P, Liu J, Poeran JV, Memtsoudis SG. Inpatient Cost of Complications after Total Hip and Knee Arthroplasty. Anesthesiology. 2026 Mar 1;144(3):611-621. doi: 10.1097/ALN.0000000000005856. Epub 2025 Nov 20.
- Martin CT, Gao Y, Pugely AJ. Incidence And Risk Factors For 30-Day Readmissions After Hip Fracture Surgery. Iowa Orthop J. 2016;36:155-60.
- Hui S, Fowler AJ, Cashmore RMJ, Fisher TJ, Schlautmann J, Body S, Lan-Pak-Kee V, Webb M, Kyriakides M, Ng JY, Chisvo NS, Pearse RM, Abbott TEF. Routine postoperative noninvasive respiratory support and pneumonia after elective surgery: a systematic review and meta-analysis of randomised trials. Br J Anaesth. 2022 Feb;128(2):363-374. doi: 10.1016/j.bja.2021.10.047. Epub 2021 Dec 13.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- Ethical Committee Number 23/26
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .